Role of vitamin D in acquired immune and autoimmune diseases

References

• Mellanby T. The part played by an accessory factor in the production of experimental rickets. J Physiol 1918;52:11–4
   Google Scholar
• McCollum EF, Simmonds N, Becker JE, Shipley PG. Studies on experimental rickets; and experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922;53:293–312
   PubMedGoogle Scholar
• Huldschinsky K. Curing rickets by artificial UV-irradiation. Deutsche Med Wochenschr 1919;45:712–3
   Google Scholar
• Hess AF, Unger LF. Cure of infantile rickets by sunlight. J Am Med Assoc 1921;77:39
   Google Scholar
• Hess AF, Pappenheimer AM. Experimental rickets in rats. III. The prevention of rickets in rats by exposure to sunlight. J Biol Chem 1922;50:77–81
   Google Scholar
• Goldblatt H, Soames KM. XXXIV. A study of rats on a normal diet irradiated daily by the mercury vapour quartz lamp or kept in darkness. Biochem J 1923;17:294–7
   PubMedGoogle Scholar
• Askew FA, Bruce HM, Callow RK, et al. Crystalline vitamin D. Nature 1931;128:758
   Google Scholar
• Windaus A. The chemistry of irradiated ergosterol. Proc Royal Soc (Lond) 1931;108:568–75
   Google Scholar
• Reerink EH, Van Wijk W. The vitamin D problem. Biochem J 1931;25:1001–9
   PubMedGoogle Scholar
• Windaus A, Thiele W. Über die Konstitution des Vitamins D2. Liebigs Ann Chem 1936;521:160–75
   Google Scholar
• Windaus A, Schenck F, von Werder F. Uber das antirachitisch wirksame Bestrahlungs-produkt aus 7-Dehydrocholesterin. Z Physiol Chem 1936;241:100–3
   Google Scholar
• Windaus A, Bock F. Über das provitamin aus dem Sterin der Schweineschwarte. Z Physiol Chem 1937;245:168–70
   Google Scholar
• Wolf G. The discovery of vitamin D: the contribution of Adolf Windaus. J Nutr 2004;134:1299–302
   PubMed Web of Science ®Google Scholar
• ThomasWC Jr , Morgan HG, Connor TB, et al. Studies of anti-ricketic activity in sera from patients with disorders of calcium metabolism and preliminary observations on the mode of transport of vitamin D in human serum. J Clin Invest 1959;38:178–85
   Web of Science ®Google Scholar
• Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 1975;72:2076–80
   PubMed Web of Science ®Google Scholar
• Holick MF, Chen T, Lu Z, Sauter E. Vitamin D skin physiology: a D-lightful story. J Bone Miner Res 2007;2:V28–33
   Google Scholar
• Lund J, DeLuca HF. Biologically active metabolite of vitamin D3 from bone, liver, and blood serum. J Lipid Res 1966;7:739–44
   PubMed Web of Science ®Google Scholar
• Blunt JW, Tanaka Y, DeLuca HF. Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. Proc Natl Acad Sci USA 1968;61:1503–6
   PubMed Web of Science ®Google Scholar
• Blunt JW, DeLuca HF. The synthesis of 25-hydroxycholecalciferol: a biologically active metabolite of vitamin D3. Biochemistry 1969;8:671–5
   PubMed Web of Science ®Google Scholar
• Holick MF, Schnoes HK, DeLuca HF, et al. Isolation and identification of 1,25-dihydroxycholecalciferol: a metabolite of vitamin D active in intestine. Biochemistry 1971;10:2799–804
   PubMed Web of Science ®Google Scholar
• Semmler EJ, Holick MF, Schnoes HK, DeLuca HF. The synthesis of 1,25-dihydroxycholecalciferol: a metabolically active form of vitamin D3. Tetrahedron Lett 1972;40:4147–50
   Google Scholar
• Brown AJ. Regulation of vitamin D action. Nephrol Dial Transplant 1999;14:11–6
   PubMed Web of Science ®Google Scholar
• Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011;25:531–41
   PubMed Web of Science ®Google Scholar
• Jones G. Expanding role for vitamin D in chronic renal disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and non-classical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial 2007;20:316–24
   PubMed Web of Science ®Google Scholar
• Haussler MR, Norman AW. Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 1969;62:155–62
   PubMed Web of Science ®Google Scholar
• Margolis RN, Christakos S. The nuclear receptor superfamily of steroid hormones and vitamin D gene regulation. An update. Ann NY Acad Sci 2010;1192:208–14
   PubMed Web of Science ®Google Scholar
• Whitfield GK, Hsieh J-C, Jurutka PW, et al. Genomic action of 1,25-dihydroxyvitamin D3. J Nutr 1995;125:1690S–4S
   Web of Science ®Google Scholar
• MacDonald PN, Baudino TA, Tokumaru H, et al. Vitamin D receptor and nuclear receptor co-activators: crucial interactions in vitamin D-mediated transcription. Steroids 2001;66:171–6
   PubMed Web of Science ®Google Scholar
• Christakos S, Norman AW. Studies on the mode of action of calciferol. XXIX. Biochemical characterization of 1,25-dihydroxyvitamin D3 receptors in chick pancreas and kidney cytosol. Endocrinology 1981;108:140–9
   PubMed Web of Science ®Google Scholar
• Norman AW. From vitamin D to hormone: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008;88:491S–9S
   PubMedGoogle Scholar
• Ordónez-Morán P, Munõz A. Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 2009;8:1675–80
   PubMed Web of Science ®Google Scholar
• Nemere I, Schwartz Z, Pedrozo H, et al. Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid action of protein kinase C. J Bone Miner Res 1998;13:1353–9
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys 2012;523:123–33
   PubMed Web of Science ®Google Scholar
• Bikle D. Non classic actions of vitamin D. J Clin Endocrinol Metab 2009;94:26–34
   PubMed Web of Science ®Google Scholar
• Lai JK, Lucas RM, Clements MS, et al. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res 2010;54:1062–71
   PubMed Web of Science ®Google Scholar
• Souberbielle JC, Prié D, Courbebaisse M, et al. Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris) 2008;69:501–10
   PubMed Web of Science ®Google Scholar
• Lips P. Vitamin D deficiency and secondary hyperparathryroidism in the elderly: consequence of bone loss and fractures and therapeutic implications. Endocrine Rev 2001;22:477–501
   PubMed Web of Science ®Google Scholar
• Aloia JF, Talwar SA, Pollack S, et al. Optimal vitamin D status and serum parathyroid hormone concentrations in African-American women. Am J Clin Nutr 2006;84:602–9
   PubMed Web of Science ®Google Scholar
• Le Goaziou MF, Contardo G, Dupraz C, et al. Risk factors for vitamin D for women aged 20-50 years consulting in general practice. Eur J Gen Pract 2011;17:146–52
   PubMed Web of Science ®Google Scholar
• Cavalier E, Rozet E, Gadivisseur R, et al. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut-offs. Osteoporos Int 2010;21:1047–51
   PubMed Web of Science ®Google Scholar
• Kobold U. Approaches to measurement of vitamin D concentrations - mass spectrometry. Scand J Clin Lab Invest 2012;72:54–9
   Web of Science ®Google Scholar
• Perna L, Haug U, Schöttker B, et al. Public health implications of standardized 25-hydroxyvitamin D levels: a decrease in the prevalence of vitamin D deficiency among older women in Germany. Prevent Med 2012;55:228–32
   PubMed Web of Science ®Google Scholar
• Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 1999;69:842–56
   PubMed Web of Science ®Google Scholar
• Vieth R, Chan P-CR, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288–94
   PubMed Web of Science ®Google Scholar
• Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington DC: National Academy Press, 1997:282. Available at http://www.nap.edu/catalog.php?record_id=5776 [last accessed 03 Mar 2014]
   Google Scholar
• Maalouf J, Nabulsi M, Vieth R, et al. Short and long-term safety of weekly high-dose vitamin D3 supplementation in school children. J Clin Endocrinol Metab 2008;93:2693–701
   PubMed Web of Science ®Google Scholar
• Haddock L, Corcino J, Vazquez MD. 25(OH)D serum levels in the normal Puerto Rican population and in subjects with tropical sprue and parathyroid disease. Puerto Rico Health Sci J 1982;1:85–91
   Google Scholar
• Kimball SM, Ursell MR, O’Connor P, Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 2007;86:645–51
   PubMed Web of Science ®Google Scholar
• Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. J Am Med Assoc 2010;303:1815–22
   PubMed Web of Science ®Google Scholar
• Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637–42
   PubMed Web of Science ®Google Scholar
• Nurmi-Lüthje I, Sund R, Juntunen M, Lüthje P. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland. J Bone Mineral Res 2011;26:1845–53
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari H, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. J Am Med Assoc 2005;293:2257–64
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of non-vertebral fractures with vitamin D and dose-dependency. Arch Intern Med 2009;169:551–61
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Int Med 2010;170:813–20
   PubMedGoogle Scholar
• Counts SJ, Baylink DJ, Shen FH, et al. Vitamin D intoxication in an anephric child. Ann Intern Med 1975;82:196–200
   PubMed Web of Science ®Google Scholar
• Mawer EB, Hann JT, Berry JL, Davies M. Vitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci 1985;68:135–41
   Web of Science ®Google Scholar
• Allen SH, Shah JH. Calcinosis and metastatic calcification due to vitamin D intoxication. A case report and review. Horm Res 1992;37:68–77
   PubMedGoogle Scholar
• Pettifor JM, Bikle DD, Cavaleros M, et al. Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 1995;122:511–3
   PubMed Web of Science ®Google Scholar
• Souberbielle JC, Courbebaisse M, Cormier C, et al. When should we measure vitamin D concentration in clinical practice? Scand J Clin Lab Invest 2012;72:129–35
   PubMed Web of Science ®Google Scholar
• Souberbielle JC. Effets cliniques de la vitamin D. In: Souberbielle JC, ed. Vitamin D. Torino, Italy: SEEdsrl; 2010:1–139
   Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1911–30
   PubMed Web of Science ®Google Scholar
• Mora JR, Iwata M, von Adrian UH. Vitamin effect on the immune system: vitamins A and D take the stage. Nature Rev Immunol 2008;5:685–98
   Google Scholar
• Adams JS, Gacad MA. Characterization of 1-alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985;161:755–65
   PubMed Web of Science ®Google Scholar
• Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 2010;32:103–11
   Google Scholar
• Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173:2909–12
   PubMed Web of Science ®Google Scholar
• Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005;19:1067–77
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770–3
   PubMed Web of Science ®Google Scholar
• Nelson CD, Reinhardt TA, Betz DC, Lippolis JD. In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during bacterial infection. PLoS One 2010;5:e15469
   PubMed Web of Science ®Google Scholar
• Yamshchikov AV, Desai NS, Blumberg HM, et al. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009;15:438–49
   PubMed Web of Science ®Google Scholar
• Peelen E, Knippenberg S, Muris AH, et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 2011;10:733–43
   PubMed Web of Science ®Google Scholar
• May E, Asadullah K, Zügel U. Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs. Curr Drug Targets Inflamm Allergy 2004;3:377–93
   PubMedGoogle Scholar
• Müller K, Bendtzen K. 1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. J Investig Dermatol Symp Proc 1996;1:68–71
   PubMedGoogle Scholar
• Van der Aar AM, Sibiryak DS, Bakdash G, et al. Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J Allergy Clin Immunol 2011;127:1532–40
   PubMed Web of Science ®Google Scholar
• Loser K, Beissert S. Regulation of cutaneous immunity by the environment: an important role for UV irradiation and vitamin D. Int Immunopharmacol 2009;9:587–9
   PubMed Web of Science ®Google Scholar
• Stoop JN, Harray RA, von Delwig A, et al. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum 2010;62:3656–65
   PubMedGoogle Scholar
• McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008;28:445–53
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 effector cytokines in inflammation. Immunity 2008;28:454–67
   PubMed Web of Science ®Google Scholar
• Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 2010;107:22593–8
   PubMed Web of Science ®Google Scholar
• Speer G. Impact of vitamin D in neurological diseases and neurorehabilitation: from dementia to multiple sclerosis. Part I: the role of vitamin D in the prevention and treatment of multiple sclerosis. Ideggyogy Sz 2013;66:293–303
   PubMedGoogle Scholar
• Smolders J, Thewissen M, Peelen E, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009;4:e6635
   PubMed Web of Science ®Google Scholar
• Hyppönen E, Läärä E, Reunanen A, et al. Intake of vitamin D and risk of Type 1 diabetes: a birth cohort study. Lancet 2001;358:1500–3
   PubMed Web of Science ®Google Scholar
• Muhe L, Lulseged S, Mason KE, Simoes EA. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997;341:1801–4
   Google Scholar
• Roth DE, Shah R, Black RE, Baqui AH. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr 2010;99:389–93
   PubMed Web of Science ®Google Scholar
• Lasksi I. Vitamin D and respiratory infection in adults. Proc Nutr Soc 2012;71:90–7
   PubMed Web of Science ®Google Scholar
• Maalmi H, Berraïes A, Tangour E, et al. The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study. J Asthma Allergy 2012;5:11–9
   PubMedGoogle Scholar
• Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol 2013;136:321–9
   PubMed Web of Science ®Google Scholar
• Bergman P, Lindh ÅU, Björkhem-Bergman L, Lindh JD. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2013;8:e65835
   PubMed Web of Science ®Google Scholar
• Burrell AM, Handel AE, Ramagopalan SV, et al. Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC). Discov Med 2011;11:187–96
   PubMed Web of Science ®Google Scholar
• Schwalfenberg GK. Solar radiation and vitamin D: mitigating environmental factors in autoimmune disease. J Environ Publ Health 2012;2012: 619381. doi: 10.1155/2012/619381. Epub 2012 Jan 11
   Google Scholar
• Chang J-H, Cha H-R, Lee D-S, et al. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of Th17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 2010;5:e12925
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Hayes CE, DeLuca HF. 1,25-Didydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996;93:7861–4
   PubMed Web of Science ®Google Scholar
• Nashold FE, Miller DJ, Hayes CE. 1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 2000;103:171–9
   PubMed Web of Science ®Google Scholar
• DeLuca HF, Plum LA. Vitamin D deficiency diminishes the severity and delays onset of experimental autoimmune encephalomyelitis. Arch Biochem Biophys 2005;513:140–3
   Google Scholar
• Fernandes de Abreu DA, Ibrahim EC, Boucraut J, et al. Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers. J Steroid Biochem Mol Biol 2010;121:250–3
   PubMed Web of Science ®Google Scholar
• Wang Y, Marling SJ, Zhu JG, et al. Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor. Proc Natl Acad Sci USA 2012; 109:8501–4
   PubMed Web of Science ®Google Scholar
• Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. Part 1: Sunlight, dietary factors and epidemiology. Int J Environ Stud 1974;6:19–27
   Web of Science ®Google Scholar
• Goldberg P. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986;21:193–200
   PubMed Web of Science ®Google Scholar
• Soilu-Hänninen M, Laaksonen M, Laitinen I, et al. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008;779:152–7
   Google Scholar
• Simpson S, Taylor B, Blizzard L, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010;68:193–203
   PubMed Web of Science ®Google Scholar
• Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D status is associated with relapse rate in paediatric-onset multiple sclerosis. Ann Neurol 2010;67:618–24
   PubMed Web of Science ®Google Scholar
• Mowry EM, Waubant E, McCulloch CE, et al. Vitamin D status predicts new brain MRI activity in multiple sclerosis. Ann Neurol 2012;72:234–40
   PubMed Web of Science ®Google Scholar
• Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 2009;256:1468–79
   PubMed Web of Science ®Google Scholar
• van Amerongen BM, Féron F. Effect of high vitamin D3 intake on ambulation, muscular pain, and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report. Int J Mol Sci 2012;13:13461–83
   PubMed Web of Science ®Google Scholar
• Burton JM, Kimball S, Vieth R, et al. A phase I/II dose escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010;74:1852–9
   PubMed Web of Science ®Google Scholar
• Smolders J, Peelen E, Thewissen M, et al. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One 2010;5:e15235–43
   PubMed Web of Science ®Google Scholar
• Knippenberg S, Smolders J, Thewissen M, et al. Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Mult Scler J 2011;17:1418–23
   PubMed Web of Science ®Google Scholar
• Pierrot-Deseilligny C, Rivaud-Péchoux S, Clerson P, et al. Relationship between 25(OH)D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord 2012;5:187–98
   PubMed Web of Science ®Google Scholar
• Mahon BD, Gordon SA, Cruz J, et al. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003;134:128–32
   PubMed Web of Science ®Google Scholar
• Mosayebi G, Ghazavi A, Ghasami K, et al. Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest 2011;40:627–39
   PubMed Web of Science ®Google Scholar
• Stein MS, Liu Y, Gray OM, et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 2011;77:1611–8
   PubMed Web of Science ®Google Scholar
• Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-bind randomised controlled trial. Mult Scler J 2012;18:1144–51
   PubMed Web of Science ®Google Scholar
• Soilu-Hänninen M, Åivo J, Lindström B-M, et al. A randomised, double-blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2012;83:565–71
   PubMed Web of Science ®Google Scholar
• Dörr J, Ohlraun S, Skarabis H, Paul F. Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial. Trials 2012;13:15–21
   PubMed Web of Science ®Google Scholar
• Smolders J, Hupperts R, Barkhof F, et al. Efficacy of vitamin D3 as an add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci 2011;311:44–9
   PubMed Web of Science ®Google Scholar
• O’Connell K, Kelly S, Kinsella K, et al. Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double-blind placebo-controlled trial. Trials 2013;14:272–9
   PubMed Web of Science ®Google Scholar
• A multicentre study of the efficacy and safety of supplementary treatment with cholecalciferol in patients with relapsing multiple sclerosis treated with subcutaneous interferon beta-1a 44 μg 3 times weekly (CHOLINE). EU Clinical Trials Register. EUDRACT 2009-013695-46
   Google Scholar
• Nokoff N, Rewers M. Pathogenesis of type-1 diabetes: lessons from natural history studies of high-risk individuals. Ann NY Acad Sci 2013;1281:1–15
   PubMed Web of Science ®Google Scholar
• Noble JA, Valdes AM, Cook M, et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996;59:1134–48
   PubMed Web of Science ®Google Scholar
• Mathieu C, Laureys J, Sobis M, et al. 1,25(OH)2D3 prevents insulitis in NOD mice. Diabetes 1992;41:1491–5
   PubMed Web of Science ®Google Scholar
• Mathieu C, Waer M, Laureys J, et al. Prevention of autoimmune diabetes in NOD mice by 1,25(OH)2D3. Diabetologia 1994;37:552–8
   PubMed Web of Science ®Google Scholar
• van Etten E, Mathieu C. Immunoregulation by 1,25(OH)2D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93–101
   PubMed Web of Science ®Google Scholar
• Peterlik M, Cross HS. Vitamin D and calcium deficits predispose to multiple chronic diseases. Eur J Clin Invest 2005;35:290–301
   PubMed Web of Science ®Google Scholar
• Brekke HK, Ludvigsson J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Paediatr Diabetes 2007;8:11–4
   PubMed Web of Science ®Google Scholar
• Littorin B, Blom P, Schölin A, et al. Lower level of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type-1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006;49:2847–52
   PubMed Web of Science ®Google Scholar
• The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for type-I (insulin-dependent) diabetes mellitus. Diabetologia 1999;42:51–4
   PubMed Web of Science ®Google Scholar
• Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type 1 diabetes in the offspring. Diabetologia 2000;43:1093–8
   PubMed Web of Science ®Google Scholar
• Viskari H, Kondrashova A, Koskela P, et al. Circulating vitamin D concentrations in two neighbouring populations with markedly different incidence of type-1 diabetes. Diabetes Care 2006;29:1458–9
   PubMed Web of Science ®Google Scholar
• Sørensen IM, Joner G, Jenum PA, et al. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type-1 diabetes in the offspring. Diabetes 2012;61:175–8
   PubMed Web of Science ®Google Scholar
• Gabbay MA, Sato MN, Finazzo C, et al. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type-1 diabetes mellitus. Arch Pediatr Adolesc Med 2012;166:601–7
   PubMedGoogle Scholar
• Bock G, Prietl B, Mader JK, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev 2011;27:942–5
   PubMedGoogle Scholar
• Bizzarri C, Pitocco D, Napoli N, et al. No protective effect of calcitriol on beta-cell function in recent-onset type-1 diabetes: the IMDIAB XIII trial. Diabetes Care 2010;33:1962–3
   PubMed Web of Science ®Google Scholar
• Walter M, Kaupper T, Adler K, et al. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 2010;33:1443–8
   PubMedGoogle Scholar
• Aljabri KS, Bokhari SA, Khan MJ. Glycemic changes after vitamin D supplementation in patients with type-1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med 2010;30:454–8
   PubMed Web of Science ®Google Scholar
• Wicklow BA, Taback SP. Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk. Ann NY Acad Sci 2006;1079:310–2
   PubMed Web of Science ®Google Scholar
• Concannon P, Chen WM, Julier C, et al. Genome-wide scan for linkage to type 1 diabetes in 2496 multiplex families from type 1 diabetes genetics consortium. Diabetes 2009;58:1018–22
   PubMed Web of Science ®Google Scholar
• Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type-1 diabetes. Nat Genet 2009;41:703–7
   PubMed Web of Science ®Google Scholar
• Cooper JD, Howson JMM, Smyth D, et al. Confirmation of novel type-1 diabetes risk loci in families. Diabetologia 2012;55:996–1000
   PubMed Web of Science ®Google Scholar
• Howson JM, Cooper JD, Smyth DJ, et al. Evidence of gene-gene interaction and age-at-diagnosis effects in type-1 diabetes. Diabetes 2012;61:3012–7
   PubMed Web of Science ®Google Scholar
• Bergholdt R, Brorsson C, Palleja A, et al. Identification of novel type-1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 2012;61:954–62
   PubMed Web of Science ®Google Scholar
• Hossein-Nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One 2013;8:e58725
   PubMedGoogle Scholar
• Yeni P (under the direction of). Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d’experts. La documentation Française. Paris: Ministère de la Santé et des Sports, 2010:139. Available at: www.sante.gouv.fr [last accessed 03 Mar 2014]
   Google Scholar
• Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011;52:396–405
   PubMed Web of Science ®Google Scholar
• Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24:1375–82
   PubMed Web of Science ®Google Scholar
• Vescini F, Cozzi-Lepri A, Borderi M, et al. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr 2011;58:163–72
   PubMed Web of Science ®Google Scholar
• Allavena C, Delpierre C, Cuzin L, et al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother 2012;67:2222–30
   PubMed Web of Science ®Google Scholar
• Brown TT, McComsey GA. Association between initiation of antiretroviral therapy with Efavirenz and decreases in 25-hydroxyvitamin D. Antiviral Ther 2010;15:425–9
   PubMed Web of Science ®Google Scholar
• Viard JP, Souberbielle JC, Kirk O, et al. Vitamin D and clinical disease progression in HIV infection: results for the EuroSIDA study. AIDS 2011;25:1305–15
   PubMed Web of Science ®Google Scholar
• Mehta S, Giovanucci E, Mugusi FM, et al. Vitamin D status of HIV-infected women and its association with HIV progression, anemia and mortality. PLoS One 2010;5:e8770
   PubMed Web of Science ®Google Scholar
• Mehta S, Hunter DJ, Mugusi FM, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009;200:1022–30
   PubMed Web of Science ®Google Scholar
• Mehta S, Mugusi FM, Spiegelman D, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 2011;25:579–85
   PubMed Web of Science ®Google Scholar
• Arpadi SM, McMahon D, Abrams EJ, et al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Paediatrics 2009;123:e12106
   Web of Science ®Google Scholar
• Giacomet V, Vigano A, Manfredini C, et al. Cholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial. HIV Clin Trials 2013;14:51–60
   PubMed Web of Science ®Google Scholar
• Kakalia S, Sochett EB, Stephens D, et al. Vitamin supplementation and CD4 count in children infected with human immunodeficiency virus. J Pediatr 2011;159:951–7
   PubMed Web of Science ®Google Scholar
• Cooper C, Thorne A. Canadian HIV Trial Network Cnt influenza vaccine research group. Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected patients. HIV Clin Trials 2011;12:275–6
   PubMed Web of Science ®Google Scholar
• Bang U, Kolte L, Hitz M, et al. Correlation of increases in 1,25-dihydroxyvitamin D during vitamin D therapy with activation of CD4+ lymphocytes in HIV-infected males. HIV Clin Trials 2012;13:162–70
   PubMed Web of Science ®Google Scholar
• Rejnmark L, Avenell A, Masud T, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012;97:2670–81
   PubMed Web of Science ®Google Scholar
• Saliba W, Barnett O, Rennert HS, Rennert G. The risk of all-cause mortality is inversely related to serum 25(OH)D levels. J Clin Endocrinol Metab 2012;97:2792–8
   Google Scholar
• Chöttker B, Ball D, Gellert C, Brenner H. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2013;12:708–18
   PubMed Web of Science ®Google Scholar
• Holmøy T, Kampman MT, Smolders J. Vitamin D in multiple sclerosis: implications for assessment and treatment. Expert Rev Neurother 2012;12:1101–12
   PubMed Web of Science ®Google Scholar
• Salzer J, Hallmans G, Nyström M, et al. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012;79:2140–5
   PubMed Web of Science ®Google Scholar
• Ross AC, Taylor CL, Yaktine AL, Del Valle HB, Committee to Review Dietary Reference Intakes (DRI) for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D (2011). Washington, DC: National Academies Press, 2011:8–9. Available at http://www.nal.usda.gov/fnic/DRI/DRI_Calcium_Vitamin_D/FullReport.pdf [last accessed on 03 Mar 2014]
   Google Scholar
• Salle BL, Duhamel JF, Souberbielle JC, et al. Rapport de l’Académie de l’académie de médecine sur la vitamine D. Bull Acad Nat Med 2012;196:1011–5
   Google Scholar
• Holick MF, Binkley NC, Bischoff Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1911–30
   PubMed Web of Science ®Google Scholar
• Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, et al. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporosis Int 2013;24:1567–77
   PubMed Web of Science ®Google Scholar
• Durup D, Jørgensen HL, Christensen J. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD Study. J Clin Endocrinol Metab 2012;97:2644–52
   PubMed Web of Science ®Google Scholar